Naltrexone for Alcohol Use Disorder: How It Works

How Naltrexone Works

When you drink alcohol, your brain releases endorphins — natural opioid-like chemicals that produce feelings of pleasure and reward. This endorphin release is a key driver of the reinforcement cycle that maintains drinking behavior. Naltrexone is an opioid antagonist: it binds to mu-opioid receptors in the brain and blocks endorphins from activating them. With naltrexone on board, drinking alcohol does not produce the expected "buzz" or reward. Over time, this pharmacological extinction weakens the association between drinking and pleasure, reducing cravings and making it easier to abstain or drink less.

Oral Naltrexone vs. Injectable Vivitrol

• •Oral naltrexone (ReVia/generic) — 50mg tablet taken daily, costs $30-60/month with insurance. Advantages: flexible dosing, easy to start and stop. Disadvantage: requires daily compliance.
• •Injectable naltrexone (Vivitrol) — 380mg intramuscular injection given once monthly by a healthcare provider. Advantages: eliminates daily compliance issues, steady medication levels. Disadvantage: higher cost ($1,000-1,500/injection before insurance), injection site reactions.
• •Both forms are equally effective when taken as prescribed. Vivitrol is often preferred for people who struggle with medication adherence or who are in early recovery and benefit from the accountability of monthly appointments.

What the Research Shows

The COMBINE study — one of the largest alcohol treatment trials ever conducted — found that naltrexone combined with medical management was as effective as specialized behavioral therapy for reducing heavy drinking. Meta-analyses of clinical trials show that naltrexone reduces the risk of heavy drinking by approximately 17% relative to placebo, reduces the number of drinking days, and significantly decreases the total amount of alcohol consumed. These effects are most pronounced when naltrexone is combined with counseling or therapy.

• •83% reduction in relapse to heavy drinking in some clinical trials
• •Approximately 36% of naltrexone patients maintain complete abstinence at 12 weeks
• •Most effective when combined with cognitive behavioral therapy or motivational enhancement
• •Benefits are sustained as long as the medication is taken
• •The Sinclair Method uses naltrexone before drinking episodes to gradually extinguish the drinking response

Who Is a Good Candidate for Naltrexone

• •People who have completed detox and are in early recovery
• •People with strong cravings for alcohol
• •People who have relapsed during previous treatment attempts
• •People who are motivated to reduce their drinking even if not ready for complete abstinence
• •People who want medication support alongside therapy

Common Side Effects

Most side effects of naltrexone are mild and tend to diminish within the first 1-2 weeks of treatment.

• •Nausea — the most common side effect, usually mild and temporary
• •Headache — typically resolves within the first week
• •Dizziness — mild and transient
• •Fatigue — some people feel tired in the first few days
• •Decreased appetite — usually temporary
• •Injection site reactions (Vivitrol) — pain, hardness, or itching at the injection site
• •Rare but serious: liver damage at very high doses (liver function should be monitored)

Starting Naltrexone: What to Expect

Your prescribing physician will order baseline liver function tests before starting naltrexone. The typical starting regimen is 25mg for the first 1-2 days (to assess tolerance), then 50mg daily thereafter. You should be alcohol-free and have completed any necessary detoxification before starting. Many people notice a reduction in cravings within the first week. Some describe a feeling of indifference toward alcohol — the obsessive thinking about drinking diminishes. If you do drink while on naltrexone, you will still become intoxicated, but the pleasurable reinforcement will be blunted.

Naltrexone and The Sinclair Method

The Sinclair Method (TSM) is an approach that uses naltrexone specifically before drinking episodes rather than daily. The patient takes naltrexone one hour before they plan to drink, allowing the medication to block the endorphin response during alcohol consumption. Over time — typically 3-4 months — this targeted pharmacological extinction gradually reduces the desire to drink. TSM has generated significant interest and has some clinical evidence supporting its effectiveness, though it remains more common in Europe than in the United States. It is best pursued under medical supervision.

Related Resources